Media Summary: Physician-scientist Stephen Kolb discusses updates in Most persons living with multiple sclerosis (MS) and Doctors diagnose 6000 American patients with the debilitating disease every year.

Als Research - Detailed Analysis & Overview

Physician-scientist Stephen Kolb discusses updates in Most persons living with multiple sclerosis (MS) and Doctors diagnose 6000 American patients with the debilitating disease every year. Fueled by a $10-million gift from the Temerty Foundation, a possible new PUBLISHED 10/30/24 We need more – likely many more – effective treatments to end ALS. Progress in ... emphasized collaboration, biomarkers, and patient-driven innovation as key to accelerating breakthroughs in

Scientists don't know what causes the neurodegenerative disease Nicholas Maragakis, director of the Johns Hopkins Adrian Isaacs, PhD is Professor of Neurodegenerative Disease at the UCL Queen Square Institute of Neurology and a founding ...

Photo Gallery

New Momentum in ALS Research
The latest in ALS research at Ohio State | Ohio State Medical Center
Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan
Clovis man's progress may prove ALS research actually working
Western researchers’ breakthrough paves way for ALS cure
Biogen's Dr. Stephanie Fradette on the Current State of ALS Research
ASK ME: ALS Research and Care in 2026
Updates on ALS Clinical Trials from Regeneron and VectorY
Inside ALS: The neurons behind the disease
University of Michigan experts warn of 10–20% increase in ALS cases over next decade
What Causes ALS? | Research Revealed | TDP-43
The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials
View Detailed Profile
New Momentum in ALS Research

New Momentum in ALS Research

There is real momentum in

The latest in ALS research at Ohio State | Ohio State Medical Center

The latest in ALS research at Ohio State | Ohio State Medical Center

Physician-scientist Stephen Kolb discusses updates in

Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan

Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan

Most persons living with multiple sclerosis (MS) and

Clovis man's progress may prove ALS research actually working

Clovis man's progress may prove ALS research actually working

Doctors diagnose 6000 American patients with the debilitating disease every year.

Western researchers’ breakthrough paves way for ALS cure

Western researchers’ breakthrough paves way for ALS cure

Fueled by a $10-million gift from the Temerty Foundation, a possible new

Biogen's Dr. Stephanie Fradette on the Current State of ALS Research

Biogen's Dr. Stephanie Fradette on the Current State of ALS Research

PUBLISHED 10/30/24 We need more – likely many more – effective treatments to end ALS. Progress in

ASK ME: ALS Research and Care in 2026

ASK ME: ALS Research and Care in 2026

... million in in

Updates on ALS Clinical Trials from Regeneron and VectorY

Updates on ALS Clinical Trials from Regeneron and VectorY

... emphasized collaboration, biomarkers, and patient-driven innovation as key to accelerating breakthroughs in

Inside ALS: The neurons behind the disease

Inside ALS: The neurons behind the disease

Amyotrophic lateral sclerosis

University of Michigan experts warn of 10–20% increase in ALS cases over next decade

University of Michigan experts warn of 10–20% increase in ALS cases over next decade

Cases of

What Causes ALS? | Research Revealed | TDP-43

What Causes ALS? | Research Revealed | TDP-43

Scientists don't know what causes the neurodegenerative disease

The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

Nicholas Maragakis, director of the Johns Hopkins

New Disease Mechanisms and Therapeutic Approaches for C9orf72 ALS/FTD

New Disease Mechanisms and Therapeutic Approaches for C9orf72 ALS/FTD

Adrian Isaacs, PhD is Professor of Neurodegenerative Disease at the UCL Queen Square Institute of Neurology and a founding ...